Iván Palomo
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities 33
- Internal Medicine top 2%
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults 14
- Hematology top 2%
- Platelet Disorders and Treatments 15
- Physiology top 2%
-
- Antiplatelet Therapy and Cardiovascular Diseases 24
-
- Pharmacology and Obesity Treatment 13
-
- Adipokines, Inflammation, and Metabolic Diseases 13
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
-
- Atherosclerosis and Cardiovascular Diseases 11
- Co-authors
- Eduardo FuentesMarcelo AlarcónLina BadimónRodrigo Moore‐CarrascoManuel Durán FuentesCèsar SepùlvedaLuís GuzmánLyanne Rodríguez
- Partner nations
- ChileSpainUnited States
In The Last Decade
Iván Palomo
182 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 167
- Biochemistry 674
- Internal Medicine 195
- Geriatrics and Gerontology 157
- Hematology 436
- Physiology 149
Countries citing papers authored by Iván Palomo
This map shows the geographic impact of Iván Palomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Palomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Palomo more than expected).
Fields of papers citing papers by Iván Palomo
This network shows the impact of papers produced by Iván Palomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Palomo. The network helps show where Iván Palomo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iván Palomo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 45 | |
| 12 | 2021 | 30 | |
| 13 | Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study | 2020 | 0 |
| 14 | 2020 | 16 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 25 | |
| 17 | 2020 | 38 | |
| 18 | 2019 | 3 | |
| 19 | 2019 | 36 | |
| 20 | Asociando el efecto de antiagregación plaquetaria de distintas especies de frutillas con antioxidantes: perfil metabolómico y transcriptómico de polifenoles | 2018 | 3 |
About Iván Palomo
Iván Palomo is a scholar working on Biochemistry, Geriatrics and Gerontology and Hematology, having authored 187 papers that have together received 4.3k indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (33 papers), Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Platelet Disorders and Treatments (15 papers), Frailty in Older Adults (14 papers), Pharmacology and Obesity Treatment (13 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Atherosclerosis and Cardiovascular Diseases (11 papers). The work is most often cited by research in Biochemistry (674 citations), Internal Medicine (195 citations) and Geriatrics and Gerontology (157 citations). Iván Palomo has collaborated with scholars based in Chile, Spain and United States. Frequent co-authors include Eduardo Fuentes, Marcelo Alarcón, Lina Badimón, Rodrigo Moore‐Carrasco, Manuel Durán Fuentes, Cèsar Sepùlveda, Luís Guzmán, Lyanne Rodríguez, Jaime Pereira and Teresa Padró. Their work appears in journals such as Molecules, Vascular Pharmacology, Platelets, Evidence-based Complementary and Alternative Medicine and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.